Cytek Biosciences, Inc.
Status: Publicly traded
Direct answer
Cytek Biosciences, Inc. is publicly traded on NASDAQ under the ticker CTKB.
Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between...
Can you invest in Cytek Biosciences, Inc.?
Yes. Cytek Biosciences, Inc. trades publicly on NASDAQ as CTKB.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Cytek Biosciences, Inc.
Detailed equity research is provided by MarketSnap.